26-valent Pneumococcal Conjugate Vaccine

BIOLOGICAL2 trials

Sponsors

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Conditions

Pneumococcal DiseasesPneumococcal Vaccines

Phase 1

Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine

CompletedNCT06703203

Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdPneumococcal Vaccines

Start: 2025-07-17End: 2026-02-05Updated: 2026-03-30

A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60

Not yet recruitingNCT06970756

Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdPneumococcal Diseases

Start: 2025-05-27End: 2026-07-10Target: 60Updated: 2025-05-18